InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by KISNER DANIEL L, Director. Officer active across 1 companies, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 3 filings have been published. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
023,109 shares0
Common Stock
SEC:0001062993-22-015042:0·
05,000 shares0
Common Stock
SEC:0001192482-21-000644·
05,000 shares0
Common Stock
SEC:0001192482-21-000644:0·
3 of 3 declarations
About KISNER DANIEL L
Daniel L. Kisner is a Board Member at Zynerba Pharmaceuticals, Inc. He is involved in governance and strategic decision-making. With expertise in the pharmaceutical sector, Daniel contributes to innovation and growth within the company.
